Showing results (211-220 of 259) with videos related to
Sort By:
Pageof 26
Acta Physiologica Scandinavica|August 1, 1985
Studies on the oxygen radical mechanism involved in the small intestinal reperfusion damageM H Schoenberg, B B Fredholm, U Haglund, et al.Annals of Surgery|September 1, 1991
Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgeryE Faist, A Markewitz, D Fuchs, et al.Lancet (London, England)|January 13, 1990
Effect of low-dose bradykinin on glucose metabolism and nitrogen balance in surgical patientsW Hartl, K W Jauch, D N Herndon, et al.International Journal of Cancer|December 20, 1995
Expression of leukocyte cell adhesion molecules on gastric carcinomas: possible involvement of LFA-3 expression in the development of distant metastasesB Mayer, C Lorenz, R Babic, et al.Zentralblatt Fur Chirurgie|November 2, 2012
[Results of surgical treatment of hiatal hernia]C W Schildberg, A Perrakis, R Croner, et al.Nature Medicine|October 1, 1995
Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancerM M Heiss, H Allgayer, K U Gruetzner, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1996
The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancerM M Heiss, R Babic, H Allgayer, et al.Anticancer Research|August 10, 2002
Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patientsR Kopp, M Ruge, E Rothbauer, et al.Clinical & Experimental Metastasis|March 21, 1998
Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patternsH Allgayer, R Babic, K U Grützner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator systemM M Heiss, R Babic, H Allgayer, et al.Pageof 26